7th Annual International Congress on Immunotherapies in Cancer™: Focus on Practice-Changing Application

Karen M. Winkfield, MD, PhD; Otis Brawley, MD; Ana Maria Lopez, MD, MPH, MACP, FRCP; Jamil Rivers

Addressing Racial and Ethnic Disparities in Breast Cancer Care: Improving Outcomes Across the Spectrum of Diagnosis, Trial Access, and Patient Care

Aditya Bardia, MD, MPH, Adriana D. Corben, MD, Hope S. Rugo, MD, FASCO, Joseph A. Sparano, MD, FACP

Next Generation Sequencing Workshop™: Breast Cancer Edition

Victor M. Rivera, MD, FAAN; Robert K. Shin, MD; Mitzi Joi Williams, MD

Community Practice Connections™: Bridging the Gap in Multiple Sclerosis—A Focus on Clinical and Health Care Disparities in Racial-Ethnic Patient Populations

Expert Illustrations & Commentaries™: Visualizing New Therapies in Uveitic Macular Edema – Understanding Impact With an Updated Armamentarium

Michael E. Wechsler, MD, MMSc; Wanda Phipatanakul, MD, MS

Alleviating Asthma Burden—Identifying and Managing Poorly Controlled Disease in Pediatric Patients

Julie R. Brahmer, MD, MSc, FASCO; Rogerio C. Lilenbaum, MD; Mark A. Socinski, MD; Everett E. Vokes, MD

Community Practice Connection™ 19th Annual Winter Lung Cancer Conference®

Immunotherapy Biomarkers and New Targets in Head and Neck Cancer

Joyce O’Shaughnessy MD; Heather L McArthur MD,  MPH; Hatem Soliman MD


Integrating New Treatment Options into the Management of Triple Negative Breast Cancer: An Expert Tumor Board Discussion

Advances in™: How Are Evolutions in DLBCL Reshaping Sequencing Considerations?

Anthony Mato, MD, MSCE; Lindsey Roeker, MD; Chaitra Ujjani, MD

Conversations and Commentaries™: Translating Evolving Data for the Use of BTK Inhibitors in CLL Into Clinical Practice

Arshad M. Khanani MD, MA; Peter K. Kaiser, MD; Sophie J. Bakri, MD

Medical Crossfire®: The Role of Inflammation in the Treatment of Diabetic Macular Edema – Expert Insights and Case Considerations

Patrick I. Borgen, MD; Joshua A. Feinberg, MD; Gary Schwartz, MD

REEL Time:  Improving Recovery Times and Quality of Life With Postoperative Opioid-Sparing Strategies for Patients With Breast Cancer

Courtney DiNardo, MD, MSCE; Keith W. Pratz, MD

Oncology Consultations®: Utilizing Molecular Testing Technologies to Inform Treatment Decision-Making in Acute Myeloid Leukemia

Rachel Grisham, MD, Leslie M. Randall, MD, MAS, FACS

Advances In™ Ovarian Cancer: Strategies For Maintenance Therapy With PARP Inhibitors In Newly Diagnosed And Relapsed Disease

Expert Illustrations & Commentaries™: Visualizing New Treatment Pathways for Anemia in Chronic Kidney Disease

Evolving Approaches in Pain Management, Regional Series - Nashville, TN

17th Annual New York Lung Cancers Symposium®

Evolving Approaches in Pain Management, Regional Series - Denver, CO

40th Annual CFS®: Innovative Cancer Therapy for Tomorrow®

Tanios Bekaii-Saab, MD; Louise C. Connell, MB, BCh BAO, BMedSc; Shikha Jain, MD, FACP

CRC Tumor Board™: Selecting and Sequencing Therapy Based on Patient and Disease-Specific Factors

6th Annual Precision Medicine Through Plasma: Using Liquid Biopsies in Contemporary Oncology Care  

Milind Javle, MD; Rondell P. Graham, MBBS'; Rachna Shroff, MD, MS

Cholangiocarcinoma Tumor Board: Utilizing Immuno-, FGFR, and IDH-Targeted Regimens and Beyond to Optimize Outcomes in Your Clinic

20th Annual School of Breast Oncology®

Jacqueline C. Barrientos, MD, MS, Jennifer R. Brown, MD, PhD, Joanna M. Rhodes, MD, MSCE, William G. Wierda, MD, PhD



 Oncology Town Hall™: Primary Investigators Present Advancements in the Management of CLL

Evolving Approaches in Pain Management, Regional Series - Tampa, FL

Ragini R. Kudchadkar, MD; Travis W. Blalock, MD, FAAD, FACMS

Oncology Consultations™: How Can Different Perspectives from Across the Care Team be Applied to Treating BCC?

Understanding Best Care Practices for Hemorrhagic Stroke – A Focus on the Role of DOAC Reversals

Oncology Consultations®: a Focus on Sequencing in Melanoma Through the Lens of Current Evidence, With an Eye Toward What’s Next

Advancing Precision Care Through Biomarker-Driven Therapy: CEACAM5 as a Therapeutic Target in NSCLC

6th Annual New York Cardio-Endo-Renal Collaborative (NY CERC)

Evolving Approaches in Pain Management, Regional Series - Atlanta, GA

Expanding Options Beyond Conventional Therapy in HR+ Breast Cancer to Overcome Unmet Needs 

Pathology Oncology Collaborative: Biomarker Testing in an Emerging Era of HER2 Across Breast, GI, and Lung Cancers

April W. Armstrong, MD, MPH, James Q. Del Rosso, DO, FAOCD, Linda F. Stein Gold, MD

Expert Illustrations and Commentaries Live: The Future of JAK/TYK2 Inhibition in the Treatment of Psoriasis

Jenny McDade Despotovic, DO; Hanny Al-Samkari, MD; Michele P. Lambert, MD, MSTR; Cindy E. Neunert, MD, MSCS

Practice Changing Evidence to Personalize Immune Thrombocytopenia Care: How the Experts Handle Cases in Today’s Environment

Expert Perspectives on the Evolving Treatment Paradigm in Heart Failure Management

Evolving Approaches in Pain Management, Regional Series - Houston, TX

From Clinical Trials to Clinical Practice – Incorporating Screening and Assessment Strategies for the Early Diagnosis of Alzheimer Disease

Taking Pompe Disease Management to the Next Level: Optimizing Clinical Assessments and Treatment Decision-Making

Medical Crossfire®: Experts Address Your Burning Questions on the Evolving Treatment of MF, PV, and ET!

4th Annual Precision Medicine Symposium: An Illustrated Tumor Board

4th Annual International Congress on the Future of Neurology®

Shaping the Management of Multiple Sclerosis: The Potential for BTK Inhibitors in Clinical Practice

The 5th Annual Advanced Practice Collaborative

School of Breast Oncology

Ajai Chari, MD; Alexander E. Drilon, MD; Daniel J. George, MD; Benjamin P. Levy, MD; Kathleen Moore, MD; Sarbajit Mukherjee, MD, MS; Christine M. Parseghian, MD; Gilles A. Salles, MD, PhD; Tiffany A. Traina, MD

Clinical Vignette Series - 39th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®

Thomas D. Coates, MD; Marina Cavazzana, MD; Antonis Kattamis, MD; Ali T. Taher, MD, PhD, FRCP

Community Practice Connections™: Improving Outcomes and Quality of Life in β-Thalassemia: Patient Perspectives and Expert Recommendations

Jorge E. Cortes, MD; Vivian Oehler, MD; Delphine Rea, MD, PhD

Aligning the Evidence With the Patient to Individualize Treatment Considerations Along the CML Care Continuum

Howard A. Liebman, MD, MA; Catherine M. Broome, MD

Community Practice Connections™: Bridging Clinical Gaps in ITP To Improve Patient Outcomes

Guillermo Garcia-Manero, MD; María Díez Campelo, MD, PhD; Rami S. Komrokji, MD; Valeria Santini, MD

Community Practice Connections™:Leveraging Clinical Data to Inform Treatment Decisions for Patients With MDS 

Ajai Chari, MD; Sikander Ailawadhi, MD; Nizar Jacques Bahlis, MD; Cesar Rodriguez Valdes, MD; Neha S. Korde, MD 

Community Practice Connections ®: New Targets, New Combinations, New Treatment Goals: Assessing Therapeutic Options to Personalize Care in Multiple Myeloma

Tanios Bekaii-Saab, MD, Joseph Chao, MD, Kristen K. Ciombor, MD, MSCI, Rondell P. Graham, MBBS

2021 Year in Review™ Reflecting on Recent Evidence and Advances in the Treatment of Gastrointestinal Cancers

William G. Wierda, MD, PhD, Peter Martin, MD, Stephen J. Schuster, MD, Michael Wang, MD,

Community Practice Connections™: Elucidating Novel BTKi Strategies in CLL/SLL and MCL: A Virtual Exploration to Bring Therapeutic Rationales and Evidence into Perspective

Hope S. Rugo, MD, FASCO; William J. Gradishar, MD, FASCO, FACP ; Komal Jhaveri, MD, FACP; Sara M. Tolaney, MD, MPH; Debu Tripathy, MD 

Community Practice Connections™: Navigating the Evolving Treatment Landscape for HR-Positive Breast Cancer

Advances In™: The Role of Pro-Tumor Inflammation Inhibition in Lung Cancer Treatment

Alexander Röth, MD; Wilma Barcellini, MD; Catherine Broome, MD; Ilene Ceil Weitz, MD

Community Practice Connections™: Cold Agglutinin Disease: Shifting the Treatment Paradigm Through Improved Understanding of the Complement System

Elliott Vichinsky, MD; Caterina P. Minniti, MD; Modupe Idowu, MD

Community Practice Connections™: Modifying the Course of Sickle Cell Disease With Modern Interventions

A. Paul Chous, OD, MA, FAAO; Danica J. Marrelli, OD, FAAO; Kelly K. Nichols, OD, PhD, MPH, FAAO; Adam Ramsey, OD; Jessica Steen, OD, FAAO

Community Practice Connections™: 1st Annual Optometry Times® EyeCon 2021

Developments in the Management of Metastatic HER2-Positive Breast Cancer and Delivery of Patient-Centered Oncology Care

Peter J. McDonnell, MD; Oluwatosin U. Smith, MD; David M. Katz, MD; Arshad M. Khanani, MD, MA

Community Practice Connections™: Focused Takeaways from the Ophthalmology Times® EyeCon 2021

Burst CME™ – Integrating the Latest Updates for PARP Inhibitors Across Ovarian Cancer

Charu Aggarwal, MD, MPH; Aditya Bardia, MD, MPH; Ryan Corcoran, MD, PhD 

Community Practice Connections™: 5th Annual Precision Medicine Through Plasma:  Using Liquid Biopsies in Contemporary Oncology Care

Alok Khorana, MD; Dana Angelini, MD; Marc Carrier, MD, MSc, FRCPC; Rachel Rosovsky, MD, MPH

Health Care Team Collaborative: Optimizing Treatment and Prevention of VTE in Patients With Hematologic Malignancies

Steven W. Pipe, MD; Stacy E. Croteau, MD, MMS; Andrew D. Leavitt, MD 

Community Practice Connections™: New Horizons in Hemophilia: Preparing for the Advent of Gene Therapy

Exploring the Advancements of Evidence-Based Testing and Treatment Strategies in CLL

James L. M. Ferrara, MD, DSc; Carrie Lynn Kitko, MD; Stephanie Lee, MD, MPH; Mark A. Schroeder, MD, MSCI

How We Do It™: Leveraging Novel Therapies and Patient Data to Inform Key Decisions in GvHD

Evolving Treatment Strategies for Adjuvant and Metastatic Melanoma: A Multidisciplinary Approach to Care

Joyce O’Shaughnessy, MD; David Euhus, MD; Tiffany A. Traina, MD; Joseph A. Sparano, MD

 School of Breast Oncology® Live Video Webcast: Clinical Updates From San Antonio

Srdan Verstovsek, MD, PhD; Andrew Kuykendall, MD; Lindsey Lyle, PA-C, MS; Laura Michaelis, MD; Abdulraheem Yacoub, MD

Community Practice Connections: DIAGNOSIS AND TREATMENT OF MF AND PV: Where Are We, and Where Are We Going?

Thomas D. Coates, MD; Paul C. Adams, MD; Tomas Ganz, PhD, MD; Janet L. Kwiatkowski, MD, MSCE

Optimizing Management of Iron Overload: Strategies to Improve Identification and Treatment

Exploring Strategies for Treating Solid Tumors With PARP Inhibitors

Hope S. Rugo, MD, FASCO; William J. Gradishar, MD, FASCO, FACP; Komal Jhaveri, MD, FACP; Sara M. Tolaney, MD, MPH; Debu Tripathy, MD 

Medical Crossfire®: Navigating the Evolving Treatment Landscape for HR-Positive Breast Cancer

Suresh S. Ramalingam, MD, FACP,  FASCO, Keith Kerr, BSc, MBChB, FRCPath, FRCPE, Luis Paz-Ares, MD, PhD, Solange Peters, MD, PhD, Tony Mok, MD, FRCPC, FASCO

PER Global® Virtual Tumor Board: EGFR Mutation Matters: Optimizing Therapy by EGFR Mutation Subtype and Co-Mutations

Javier Pinilla-Ibarz, MD, PhD; Jacqueline C. Barrientos, MD, MS; Catherine C. Coombs, MD; Nilanjan Ghosh, MD, PhD

Medical Crossfire®: How Can We Maximize Outcomes With PI3K Inhibitors Across Hematologic Malignancies?

Ifeyinwa Osunkwo, MD, MPH; Biree Andemariam, MD; Bernard L Lopez, MD, MS, CPE

Sickle Cell Disease: Improving the Quality and Continuum of Acute and Ambulatory Patient Care

19th Annual Meeting of the International Society of Gastrointestinal Oncology®

Craig M. Kessler, MD, MACP; Cindy Leissinger, MD; Steven W. Pipe, MD

Managing the Whole Patient with Hemophilia A: Clinical Evidence and Practical Strategies

Community Practice Connections™: 16th Annual New York Lung Cancers Symposium®

Elucidating Novel BTKi Strategies in CLL/SLL and MCL: A Virtual Exploration to Bring Therapeutic Rationales and Evidence into Perspective

Naveen Pemmaraju, MD; Marina Konopleva, MD, PhD

Advances in™: Diagnosis and Treatment of BPDCN Around the World!

Kathleen N. Moore, MD, MS; Ritu Salani MD, MBA

Oncology Consultations™: How Do The Experts Utilize PARP Inhibitors in Ovarian Cancer Across Lines of Care?

Roy S. Herbst, MD, PhD; Alberto Chiappori, MD; W. Victoria Lai, MD; Jared Weiss, MD

2nd Annual Virtual Tumor Board®: Navigating Novel Therapeutic Approaches for the Management of SCLC Across Lines of Care

Medical Crossfire®: Applying the Evidence in Acute Lymphoblastic Leukemia From Pediatric to Adult Case Scenarios

PEeR Exchange® Assessing Racial and Ethnic Disparities in Lung Cancer Care

Fred R. Hirsch, MD, PhD; Lynette M. Sholl, MD

Advances In™: How the Experts Treat Oncogene-Driven Advanced NSCLC

Oncology Briefings™: Updates in the Treatment of GEP-NETs

Advances In™: Clinical Impact of Novel Emerging Treatment Options for PK Deficiency

Christopher R. Flowers, MD, MS, FASCO; Laurie H. Sehn, MD, MPH

Cancer Summaries and Commentaries: Report from Atlanta on Advances in the Treatment of DLBCL

Medical Crossfire®: Sequencing of Disease Modifying Therapies – Optimizing Outcomes in Patients with Multiple Sclerosis

Medical Crossfire®: How the Experts Identify and Target EGFR exon 20 Insertion Mutations Across Lines of Care in NSCLC

Oncology Consultations®: Addressing the Risk and Burden of CNS Metastases in HER2+ Breast Cancer to Improve Patient Outcomes

David J. Kuter, MD, DPhil; Hanny Al-Samkari, MD; Spero Cataland, MD; Ilene Weitz, MD

Medical Crossfire®: Bridging The Gap Between Diagnosis and Treatment in Hemolytic Anemias

Ajai Chari, MD; Sikander Ailawadhi, MD; Nizar Jacques Bahlis, MD; Neha S. Korde, MD; Cesar Rodriguez Valdes, MD

New Targets, New Combinations, New Treatment Goals: Assessing Therapeutic Options to Personalize Care in Multiple Myeloma

Medical Crossfire: Personalized Regimens for Managing Hemophilia A: Selecting an Optimal Recombinant FVIII Agent

Virtual Hot Seat™: Experts Face Key Questions to Maximize the Use of PI3K Inhibitors Across Hematologic Malignancies

Steven Horwitz, MD; Alison J Moskowitz, MD

Oncology Consultations®: Applying the Latest Advances in Treatment of PTCL and CTCL with an Eye Toward the Future of Care

Community Practice Connections™: Optimizing Management of Uveitic Macular Edema With Potential Treatments on the Horizon

Anthony J. Aldave, MD; Clara C. Chan, MD, FRCSC, FACS, DABO

(COPE Credit) Expert Illustrations & Commentaries™: Visualizing Corneal Innervation, Pathophysiology, and Treatment Mechanisms in Neurotrophic Keratitis

1.0 Credit / Immunology, Neurology, Rare Diseases

Continuing Education

Latest News